Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Ilan Ganot | Director | 2024-01-29 | 139 | $7.99 | $1.11kSell |
Adam Koppel | Director | 2024-01-11 | 904,160 | $5.53 | $5.00MBuy |
Bain Capital Life Sciences Investors LLC | Director | 2024-01-11 | 904,160 | $5.53 | $5.00MBuy |
Ra Capital Management LP | Director | 2024-01-11 | 904,160 | $5.53 | $5.00MBuy |
Perceptive Advisors LLC | Director | 2024-01-11 | 3,410,713 | $5.53 | $18.86MBuy |
Kevin Tan | CFO Treasurer | 2024-01-09 | 3,935 | $8.20 | $32.27kSell |
Ilan Ganot | Director | 2024-01-03 | 1,142 | $5.30 | $6.05kSell |
David T. Howton | Chief Operating Officer | 2023-12-04 | 5,367 | $2.78 | $14.92kSell |
Jessie Hanrahan | Chief Regulatory Officer | 2023-12-04 | 4,879 | $2.78 | $13.56kSell |
Paul Herzich | Chief Technology Officer | 2023-12-04 | 2,968 | $2.77 | $8.23kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Rajeev M. Shah | 35.18% | 13,281,046 | $130.42M | Insider |
Ra Capital Management LP | 30.96% | 11,689,948 | $114.80M | Insider |
Ultragenyx Pharmaceutical Inc | 20.73% | 7,825,797 | $76.85M | Insider |
Gilad David Hayeem | 13.60% | 5,136,501 | $50.44M | Insider |
Bain Capital Life Sciences Investors LLC | 10.69% | 4,034,582 | $39.62M | Insider |
Adam Koppel | 10.69% | 4,034,582 | $39.62M | Insider |
Matthew Bennett Arnold | 10.42% | 3,933,429 | $38.63M | Insider |
Perceptive Advisors LLC | 9.26% | 3,495,933 | $34.33M | Institution |
Boxer Capital LLC | 9.20% | 3,473,272 | $34.11M | Insider |
Ra Capital Management LP | 9.07% | 3,426,286 | $33.65M | Institution |